Image courtesy of Robocath
October 18, 2019 — Robocath recently announced the success of its first two coronary angioplasties performed with assistance from its R-One robotic platform. The procedures were performed in France at Rouen University Hospital by Prof. Eric Durand and Prof. Remi Sabatier and at Clinique Pasteur in Toulouse by Jean Fajadet, M.D.
R-One assists interventional cardiologists in performing coronary angioplasties. The robotic platform is designed to facilitate and enhance interventional procedures performed for the patient and offers a better working environment for physicians and the entire medical team.
This prospective clinical study is the first of its kind to be conducted in Europe. It involves six European centers, three of which are based in France (Rouen University Hospital, Caen University Hospital, Clinique Pasteur in Toulouse). The study will involve 60 patients and aims to demonstrate the safety and efficacy of the robotic-assisted platform R-One in coronary angioplasties.
Durand, interventional cardiologist at Rouen University Hospital, commented, "I feel particularly privileged to have been given the opportunity several years ago to participate in this project and to now arrive at this first procedure in a human with excellent results."
"I am delighted with the success of these procedures. It is rewarding to see Rouen University Hospital continuing to support cutting-edge innovations in the medical sector, nearly 20 years after conducting our first aortic valve implantation in the same operating room," said Alain Cribier, professor emeritus in interventional cardiology and inventor of transcatheter aortic valve implantation (TAVI).
Fajadet, co-director of the Interventional Cardiology Unit at Clinique Pasteur in Toulouse, continued, "I am very happy with the success of these procedures and confident regarding the study results. We are on the cusp of a major revolution in the field of interventional cardiology, thanks to the possibilities opened up by vascular robotics that we are developing at Clinique Pasteur."
Sabatier, interventional cardiologist at Caen University Hospital, added, "It was an honor for me to participate to this first robotized angioplasty. I’m delighted to share the joy of the teams who accompanied us on this adventure, which I’m looking forward to continuing at Caen University Hospital."
For more information: www.robocath.com
May 31, 2022 
